Dr. Ryan Sultan - ADHD Medication Expert

Non-Stimulant ADHD Medications: Complete Guide

By Dr. Ryan Sultan, MD
Double Board-Certified Psychiatrist (Adult & Child/Adolescent)
Columbia University Irving Medical Center | Integrative Psych NYC


HomeADHD ResourcesNon-Stimulant ADHD Medications

📂 Category: ADHD Treatment Options

Home | ADHD Guide | ADHD Medications | ADHD Treatment NYC | Contact


Non-stimulant ADHD medications (Strattera, Wellbutrin, Intuniv, Qelbree) are alternatives for patients who can't tolerate stimulants, have substance use history, or have comorbid anxiety. Response rate is 40-50% vs 70-80% for stimulants.


💊 Non-Stimulant ADHD Medications: When They're the Right Choice

Stimulants are the first-line treatment for ADHD—but they're not for everyone. Non-stimulant medications offer an alternative for people who can't tolerate stimulants, have contraindications, or simply respond better to non-stimulant options.

This guide covers everything you need to know about non-stimulant ADHD medications, from effectiveness to side effects to how to choose the right one.


Table of Contents


Why Choose Non-Stimulant ADHD Medications?

Stimulants (Adderall, Vyvanse, Ritalin, Concerta) are the gold standard for ADHD treatment—but there are many good reasons to consider non-stimulants. (Note: Learn about evidence-based medication classification beyond the "stimulant" vs "non-stimulant" labels.)

Medical Contraindications to Stimulants

Intolerable Side Effects from Stimulants

Substance Use History

Practical Considerations

Personal Response


How Effective Are Non-Stimulants vs. Stimulants?

The honest answer: Stimulants are more effective for most people, but non-stimulants work well for many.

Response Rates

Medication Type Response Rate Effect Size
Stimulants (overall) 70-80% 0.9-1.0 (large)
Strattera 40-50% 0.6-0.7 (medium)
Wellbutrin 40-50% 0.4-0.5 (small-medium)
Intuniv 30-40% 0.6-0.7 (medium)
Qelbree 45-55% 0.6-0.7 (medium)

What this means:

What "Response" Means

A "response" typically means at least a 25-30% reduction in ADHD symptoms plus functional improvement (better at work/school, relationships, daily tasks).

This doesn't mean symptoms disappear—it means meaningful improvement in quality of life.

Time to Effect

Medication Time to Full Effect
Stimulants 30-60 minutes (same day)
Strattera 4-6 weeks
Wellbutrin 4-8 weeks
Intuniv 2-4 weeks
Qelbree 4-6 weeks

Major difference: Non-stimulants require patience. You won't know if they're working for several weeks, unlike stimulants which work immediately.


Strattera (Atomoxetine): The Most Studied Non-Stimulant

Strattera was the first non-stimulant medication FDA-approved specifically for ADHD (2002). It's the most researched and most commonly prescribed non-stimulant.

How Strattera Works

Strattera is a selective norepinephrine reuptake inhibitor (NRI). It increases norepinephrine in the prefrontal cortex, improving attention and executive function.

Unlike stimulants (which affect both dopamine and norepinephrine immediately), Strattera works gradually over weeks.

Effectiveness

Dosing

Starting dose: 40 mg once daily (or 25 mg for children)

Target dose: 80-100 mg daily (1.2-1.4 mg/kg body weight)

Maximum dose: 100 mg daily

Timing: Can be taken once daily (morning or evening) or split into two doses. Taking at bedtime may reduce nausea.

Side Effects

Common (>10%):

Less common but notable:

Rare but serious:

Advantages of Strattera

Disadvantages of Strattera

Who Strattera Works Best For


Wellbutrin (Bupropion): The Dual-Purpose Option

Wellbutrin is technically an antidepressant, but it's commonly used off-label for ADHD. It's FDA-approved for depression and smoking cessation, but not ADHD—yet it's widely prescribed for ADHD.

Read our detailed guide: Wellbutrin for ADHD: Complete Evidence Review →

How Wellbutrin Works

Wellbutrin is a norepinephrine-dopamine reuptake inhibitor (NDRI). It increases both dopamine and norepinephrine—similar mechanism to stimulants, but much weaker and slower.

Effectiveness for ADHD

Dosing

Starting dose: 150 mg XL once daily

Target dose: 300 mg XL once daily

Maximum dose: 450 mg XL daily (rarely needed for ADHD)

Formulations:

Side Effects

Common:

Serious but rare:

Advantages of Wellbutrin

Disadvantages of Wellbutrin

Who Wellbutrin Works Best For


Intuniv (Guanfacine): For Hyperactivity & Emotional Regulation

Intuniv (extended-release guanfacine) is an alpha-2 agonist originally developed as a blood pressure medication. It's FDA-approved for ADHD in children and adolescents (ages 6-17), commonly used off-label in adults.

How Intuniv Works

Intuniv stimulates alpha-2A receptors in the prefrontal cortex, improving working memory and impulse control. It also reduces norepinephrine in other brain regions, which calms hyperactivity.

Effectiveness

Dosing

Starting dose: 1 mg once daily

Target dose: 2-4 mg daily

Maximum dose: 4 mg daily

Timing: Take at bedtime (causes sedation)

Side Effects

Common:

Serious:

Advantages of Intuniv

Disadvantages of Intuniv

Who Intuniv Works Best For


Qelbree (Viloxazine): The Newest FDA-Approved Option

Qelbree (viloxazine ER) is the newest non-stimulant ADHD medication, FDA-approved in 2021 for ages 6+.

How Qelbree Works

Qelbree is a norepinephrine reuptake inhibitor (NRI)—similar mechanism to Strattera, but with additional serotonin effects. The exact mechanism isn't fully understood.

Effectiveness

Dosing

Starting dose: 100 mg once daily (or 200 mg for adults)

Target dose: 200-400 mg daily (adults), 100-600 mg (children, weight-based)

Maximum dose: 600 mg daily

Timing: Once daily in the morning (can take with or without food)

Side Effects

Common:

Serious but rare:

Advantages of Qelbree

Disadvantages of Qelbree

Who Qelbree Works Best For


Clonidine & Kapvay: Blood Pressure Medications for ADHD

Clonidine and its extended-release version Kapvay are alpha-2 agonists (same class as Intuniv). Originally blood pressure medications, they're FDA-approved for ADHD.

Clonidine vs. Guanfacine (Intuniv)

Very similar mechanisms and effects. Main differences:

Clonidine is less commonly used for ADHD because the sedation is more pronounced and the cognitive benefits are weaker than Intuniv. But it's a good option for:

Since clonidine is less commonly used as a primary ADHD medication, we'll focus the rest of this guide on Strattera, Wellbutrin, Intuniv, and Qelbree.


Side-by-Side Comparison of All Non-Stimulants

Factor Strattera Wellbutrin Intuniv Qelbree
FDA-approved for ADHD? Yes No (off-label) Yes (ages 6-17) Yes (ages 6+)
Response rate 40-50% 40-50% 30-40% 45-55%
Time to effect 4-6 weeks 4-8 weeks 2-4 weeks 4-6 weeks
Best for Inattention, anxiety ADHD + depression Hyperactivity, tics Inattention (Strattera alternative)
Worst side effect Nausea (20-30%) Insomnia, anxiety Sedation (40-50%) Drowsiness (15-20%)
Sexual side effects Yes (5-10%) No (neutral) Rare Rare
Weight effect Decreased appetite Neutral or loss Neutral Decreased appetite
Sleep effect Variable Insomnia (take AM) Improves (take PM) Variable
Controlled substance? No No No No
Cost (generic) $50-150/mo $10-30/mo $30-80/mo No generic yet ($300-500)
Dosing frequency Once or twice daily Once daily Once daily (bedtime) Once daily

Combining Non-Stimulants with Stimulants

Many people take both a stimulant and a non-stimulant. This is called combination therapy or adjunctive treatment.

Why Combine?

Common Combinations

Combination Why This Works
Stimulant + Strattera Stimulant for daytime focus, Strattera for 24-hour baseline coverage. Strattera reduces stimulant rebound.
Stimulant + Intuniv Stimulant for focus, Intuniv for hyperactivity/impulsivity and sleep. Very common in children. Intuniv smooths stimulant irritability.
Stimulant + Wellbutrin Stimulant for ADHD, Wellbutrin for comorbid depression or energy/motivation boost.
Strattera + Intuniv Two non-stimulants covering different symptoms (attention + hyperactivity). For people who can't take stimulants at all.

Safety of Combinations

Combining stimulants with non-stimulants is generally safe and well-studied. However:


How to Choose the Right Non-Stimulant

Here's a decision guide based on your specific situation:

Choose Strattera if:

Choose Wellbutrin if:

Choose Intuniv if:

Choose Qelbree if:


Switching from Stimulants to Non-Stimulants

If you're switching from a stimulant to a non-stimulant, here's what to expect:

The Process

Option 1: Gradual Crossover (Preferred)

  1. Week 1-2: Start non-stimulant at low dose while continuing stimulant
  2. Week 3-4: Increase non-stimulant dose, continue stimulant
  3. Week 5-6: Reach target non-stimulant dose, begin reducing stimulant
  4. Week 7+: Taper off stimulant completely if non-stimulant is working

Advantage: Continuous ADHD coverage, gives non-stimulant time to work before stopping stimulant

Option 2: Immediate Switch

  1. Stop stimulant
  2. Start non-stimulant same day
  3. Wait 4-6 weeks to see if it works

Disadvantage: 4-6 weeks with poor ADHD control while waiting for non-stimulant to work

Withdrawal from Stimulants

Stimulants don't cause physical dependence, but you may experience:

This is temporary and resolves within a week.

What if the Non-Stimulant Doesn't Work?

If after 6-8 weeks at target dose you see no improvement:


Frequently Asked Questions

Can I take non-stimulant ADHD medications while pregnant or breastfeeding?

Pregnancy: None of the non-stimulants are well-studied in pregnancy. Generally considered lower risk than stimulants, but still discuss with your OB. Wellbutrin (Category C) has the most pregnancy data. Strattera and Intuniv are also Category C.

Breastfeeding: Small amounts pass into breast milk. Risk/benefit discussion with your doctor needed.

Do non-stimulants show up on drug tests?

No. Non-stimulant ADHD medications do NOT show up on standard drug screenings. Stimulants (amphetamines) do show up, which can be problematic for some jobs or athletic competitions. This is a major advantage of non-stimulants.

Can I drink alcohol while taking non-stimulant ADHD medications?

Strattera: Alcohol may increase side effects (drowsiness, dizziness). Moderate to avoid.

Wellbutrin: Alcohol lowers seizure threshold. Avoid heavy drinking. Moderate amounts usually okay.

Intuniv: Alcohol + Intuniv both lower blood pressure → dangerous. Avoid.

Qelbree: Limited data. Moderate alcohol likely okay.

Will I build tolerance to non-stimulant ADHD medications?

No. Unlike stimulants (where some people build tolerance), non-stimulants maintain effectiveness long-term. You won't need to keep increasing the dose over time.

Can I stop non-stimulants suddenly or do I need to taper?

Strattera: Can stop suddenly (no withdrawal syndrome)

Wellbutrin: Can stop suddenly for ADHD doses, though gradual taper preferred to avoid mood dip

Intuniv: MUST taper slowly (risk of rebound high blood pressure if stopped abruptly)

Qelbree: Can stop suddenly

How long do I need to take non-stimulant ADHD medications?

ADHD is a chronic condition. Most people need medication long-term (years to lifelong). However:

Can children take non-stimulant ADHD medications?

Yes. All four non-stimulants (Strattera, Intuniv, Qelbree, Clonidine) are FDA-approved for children ages 6+. They're commonly used when:

Are non-stimulants addictive?

No. None of the non-stimulant ADHD medications have abuse potential. They don't produce euphoria, don't cause dependence, and aren't sought by people misusing substances. This is a major safety advantage over stimulants.


Getting Non-Stimulant ADHD Treatment in NYC

📞 Expert Non-Stimulant ADHD Medication Management

Dr. Ryan Sultan, MD specializes in ADHD medication management for adults and children in New York City. As a Columbia University faculty member with expertise in psychopharmacology, Dr. Sultan can help you:

  • Determine if non-stimulants are right for you
  • Choose between Strattera, Wellbutrin, Intuniv, and Qelbree
  • Manage side effects and optimize dosing
  • Combine non-stimulants with stimulants if needed
  • Switch from stimulants to non-stimulants safely

Locations:

  • Chelsea: 80 Eighth Avenue, Suite 1501, New York, NY 10011
  • Columbia: 1051 Riverside Drive, New York, NY 10032

Contact:
Email: rs0000@columbia.edu
Phone: 212-305-6001
Book Online at Integrative Psych →


Related Resources


ADHD Resources

ADHD Guide
Diagnosis
Medications
ADHD in Women
Children
Self-Assessment

Clinical Content

RSD
ADHD Paralysis
ADHD Burnout
OCD & ADHD
ADHD vs Autism

Research & Publications

Publications
Research Grants
Articles
Presentations
Blog

About & Contact

Profile
CV
Contact
Practice
ADHD Services NYC


📚 Related ADHD Resources

Explore comprehensive medication information: